drugset
drugset / Trial / NCT05925686

Tramadol to Improve Its Detection in Biological Matrices in Anti-doping Controls

NCT05925686 ↗

Phase 1 Completed 25 enrolled Parc de Salut Mar
NaSingle-groupOpen-labelScreening

Summary

Orally single dose administration of Tramadol 75 mg for ultra-rapid metabolizers and 100 mg for extensive and poor metabolizers will be administered with the objective to evaluate urine and blood concentrations in healthy volunteers.

Timeline

Start
2023-06-01
Primary completion
2023-10-11
Completion
2023-10-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 75 mg Oral
Subject Tramadol Other / unclassified 100 mg Oral

Indications

No indication recorded.